levodopa has been researched along with curcumin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Angelé-Martínez, C; Battin, EE; Brumaghim, JL; García, CR; Wang, HC; Wilkes, JA | 1 |
| Jadhav, J; Patil, S; Srinivas, S | 1 |
| Aliev, G; Cacabelos, R; Carrera, I; Fernandez-Novoa, L; Sampedro, C; Tarasov, VV | 1 |
| Cózar-Bernal, MJ; García Esteban, E; González-Rodríguez, ML; Rabasco Álvarez, AM | 1 |
| Choi, DH; Go, J; Han, PL; Hwang, JH; Kim, KS; Kim, YH; Lee, CH; Noh, JR; Park, HY; Rhee, M; Ryu, YK | 1 |
| Appel, JM; Borsali, R; Cardoso, MA; da Rosa, NN; de Carvalho, KAT; de Oliveira, NB; Dziedzic, DSM; Halila, S; Irioda, AC; Mogharbel, BF; Perussolo, MC; Saçaki, CS; Slompo, RC; Stricker, PEF; Travelet, C | 1 |
| Cui, C; Han, Y; Li, G; Li, H; Yu, H; Zhang, B | 1 |
1 review(s) available for levodopa and curcumin
| Article | Year |
|---|---|
Dopaminergic Neuroprotection with Atremorine in Parkinson´s Disease.
Topics: Animals; Curcumin; Dopaminergic Neurons; Ginsenosides; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Resveratrol; Vicia faba | 2018 |
7 other study(ies) available for levodopa and curcumin
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Prevention of iron- and copper-mediated DNA damage by catecholamine and amino acid neurotransmitters, L-DOPA, and curcumin: metal binding as a general antioxidant mechanism.
Topics: Antioxidants; Catecholamines; Copper; Curcumin; DNA Damage; Electrochemistry; Iron; Kinetics; Levodopa; Neurotransmitter Agents; Oxidation-Reduction | 2012 |
Evaluation of crocin and curcumin affinity on mushroom tyrosinase using surface plasmon resonance.
Topics: Agaricales; Carotenoids; Curcumin; Enzyme Inhibitors; Enzymes, Immobilized; Levodopa; Monophenol Monooxygenase; Protein Binding; Surface Plasmon Resonance | 2014 |
A comparative study of stabilising effect and antioxidant activity of different antioxidants on levodopa-loaded liposomes.
Topics: Antioxidants; Antiparkinson Agents; Ascorbic Acid; Curcumin; Dopamine Agents; Drug Liberation; Drug Stability; Levodopa; Lipid Bilayers; Liposomes; Superoxide Dismutase | 2018 |
Effects of histone acetyltransferase inhibitors on L-DOPA-induced dyskinesia in a murine model of Parkinson's disease.
Topics: Anacardic Acids; Animals; Antiparkinson Agents; Curcumin; Cytoskeletal Proteins; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Fos-Related Antigen-2; Gene Expression Regulation; Histone Acetyltransferases; Histone Code; Levodopa; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Oxidopamine; Parkinsonian Disorders; Proto-Oncogene Proteins c-fos; Specific Pathogen-Free Organisms; Substantia Nigra; Terpenes | 2018 |
Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson's Disease.
Topics: Animals; Curcumin; Drug Carriers; Levodopa; Nanoparticles; Parkinson Disease; Polyesters; Polyethylene Glycols; Polymers; Rats | 2022 |
Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Creatine; Curcumin; Disease Models, Animal; Gastrointestinal Microbiome; Levodopa; Metabolome; Methionine; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases; Neuroprotective Agents; Parkinson Disease; RNA, Ribosomal, 16S; Sarcosine | 2022 |